Acorda Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Acorda Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q2 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending March 31, 2024 was $4.69M, a 213% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $4.69M +$3.19M +213% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $4.19M +$3.94M +1589% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $3.65M +$3.4M +1377% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.9M +$2.65M +1069% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.5M +$1.49M +13509% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $248K +$237K +2155% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $247K +$236K +2145% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $248K +$237K +2155% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $11K $0 0% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $11K $0 0% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $11K $0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $11K $0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $11K $0 0% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $11K -$18K -62.1% Dec 31, 2020 10-K 2022-03-18
Q3 2020 $11K -$282K -96.2% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $11K -$283K -96.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $11K -$284K -96.3% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $29K -$127K -81.4% Dec 31, 2019 10-K 2021-03-16
Q3 2019 $293K -$126K -30.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $294K -$384K -56.6% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $295K -$199K -40.3% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $156K -$594K -79.2% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $419K -$8.09M -95.1% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $678K -$7.83M -92% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $494K -$8.64M -94.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $750K -$5.11M -87.2% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $8.51M +$2.69M +46.3% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $8.51M +$2.63M +44.8% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $9.14M +$8.9M +3723% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $5.86M +$5.61M +2270% Dec 31, 2016 10-K/A 2018-03-09
Q3 2016 $5.81M +$307K +5.58% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $5.88M +$155K +2.71% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $239K -$5.69M -96% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $247K -$5.89M -96% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $5.51M -$834K -13.2% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $5.72M -$766K -11.8% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $5.93M +$5.59M +1660% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $6.14M +$5.79M +1643% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $6.34M +$5.97M +1586% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $6.49M +$6.1M +1555% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $337K -$76K -18.4% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $352K -$85K -19.5% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $376K -$131K -25.8% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $392K -$136K -25.8% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $413K -$125K -23.2% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $437K -$40K -8.39% Dec 31, 2012 10-K 2014-03-03
Q3 2012 $507K +$30K +6.29% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $528K +$90K +20.5% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $538K +$229K +74.1% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $477K +$134K +39.1% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $477K +$118K +32.9% Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $438K +$55.6K +14.5% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $309K Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $343K Dec 31, 2010 10-K 2012-02-28
Q3 2010 $359K Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $382K Jun 30, 2010 10-Q 2010-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.